摘要
占肺癌80%的非小细胞肺癌(NSCLC)确诊时,能手术者仅占20%~30%,局部晚期者约为30%-40%,有区域和远处转移者占40%。约64.3%的NSCLC需放疗。因此,放疗在局部晚期NSCLC治疗中占有非常重要的位置。
出处
《中华放射肿瘤学杂志》
CSCD
北大核心
2007年第4期317-320,共4页
Chinese Journal of Radiation Oncology
参考文献51
-
1Barbera L, Zhang-Salomons J, Huang J, et al. Defining the need for radiotherapy for lung cancer in the general population: a criterionbased, benchmarking approach. Med Care, 2003,41 : 1074-1085.
-
2Mountain CF. Revisions in the international system for staging lung cancer. Chest, 1997,111 : 1710-1717.
-
3Greessen EL, Curran WJ. Hyperfractionated radiotherapy for lung cancer. Curr Oncol Rep, 2000,2:71-75.
-
4Kubota K, Furuse K, Kawahara M, et al. Role of radiotherapy in combined modality treatment of locally advanced non-small-cell lung cancer. J Clin Oncol, 1994,12 : 1547-1552.
-
5Auperin A, le Pechoux C, Pignon JP, et al. Concomitant radiochemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC) : a meta-analysis of individual data from 1764 patients. Ann Oncol,2006,17:473-483.
-
6Dillman RO, Hemdon J, Seagren SL, et al. Improved survival in stage Ⅲ non-small-cell lung cancer: seven-year follow-up of Cancer and Leukemia Group B (CALGB) 8433 trial. J Natl Cancer Inst, 1996,88 : 1210-1215.
-
7le Chevalier T, Arriagada R, Quoix E, et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients. J Natl Cancer Inst,1991,83 :417423.
-
8Sause W, Kolesar P, Taylor S, et al. Final results of phase Ⅲ trial in regionally advanced unresectable non-small cell lung cancer: radiation therapy oncology group, eastern cooperative oncology group, and southwest oncology group. Chest,2000,117:358-364.
-
9Rosenthal DI, Pistenmaa DA, Glatstein E. A review of neoadjuvant chemotherapy for head and neck cancer: partially shrunken tumors may be both leaner and meaner. Int J Radiat Oncol Biol Phys, 1994, 28:315-320.
-
10Schaake-Koning C, van den Bogaert W, Dalesio O, et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med, 1992,326:524-530.
二级参考文献29
-
1李连弟,鲁凤珠,张思维,牧人,孙秀娣,皇甫小梅,孙杰,周有尚,欧阳宁慧,饶克勤,陈育德,孙爱明,薛志福,夏毅.中国恶性肿瘤死亡率20年变化趋势和近期预测分析[J].中华肿瘤杂志,1997,19(1):3-9. 被引量:869
-
2Asheroft T, Simpson JM, Tumbrell V, et al. Simple method of estimating severity of pulmonary fibrosis an a numerical scale. J Clin Pathol,1988,41:467-470.
-
3冯勤富.放化疗相互作用与肺组织损伤[J].中华放射肿瘤学杂志,2003,12:86-88.
-
4Byhardt RW, Scott C, Sause WT, et al. Response, toxicity, failure patterns, an d survival in five radiation therapy oncology group (RTOG) trial of sequential a nd/or concurrent chemotherapy radiation therapy for local advanved non-small cell lung cancer. Int J Radiat Oncol Biol Phys,1998,42:469-478.
-
5Yamada M, Kudoh S, Hirata K. Risk factors of pneumonitis following chemotherap y for lung cancer. Eur J Cancer,1998,34:71-75.
-
6Willner J, Schmidt M, Kirschner J, et al. Sequential chemo- and radiotherapy with weekly paclitaxel(Taxol) and 3D-conformal radiotherapy of stage III inopera b le non-small cell lung cancer. Results of a dose escalation study. Lung Cancer, 2001,32:163-171.
-
7Willner J, Jost A, Baier K, et al. A little to a lot or a lot to a little An analysis of pneumonitis risk from dose-volume histogram parameters of the lung in patients with lung cancer treated with 3-D conformal radiotherapy. Strahlenther Onkol,2003,179:548-556.
-
8Oral EN, Bavbek S, Kizir A, et al. Preliminary analysis of phase II study of paclitaxel and CHART in locally advanced non-small cell lung cancer. Lung Cancer ,1999,25:191-198.
-
9McInerney DP, Bullimore J. Reactivation of radiation pneumonitis by adriamycin . Br J Radiol,1977,8:224.
-
10Willner J, Vordermark D, Schmidt M, et al. Secretory activity and cell cycle alteration of alveolar type II cells in the early and late phase after irradiation.Int J Radiat Oncol Biol Phys,2003,55:617-625.
共引文献107
-
1李以元.31例局部晚期非小细胞肺癌经新辅助化疗和三维适形放疗的临床疗效及安全性分析[J].医学信息(医学与计算机应用),2014,0(5):168-168.
-
2周诚忠,夏炎春,夏海波.三维适形放射治疗老年非小细胞肺癌60例[J].东南国防医药,2009,11(1):20-21. 被引量:1
-
3龙洪清,谢丛华,周福祥,张弓,梁辰,邓涤,张俊红,周云峰.后程适形放疗治疗Ⅲ期非小细胞肺癌无进展生存期影响因素分析[J].肿瘤学杂志,2009,15(12):1069-1072.
-
4湛永滋,黄昌杰,黄剑峰.非小细胞肺癌三维适形放射治疗的临床研究[J].肿瘤学杂志,2009,15(12):1073-1075. 被引量:1
-
5曾自力,刘兵.肺癌肺内肿瘤不同能量三维适形放疗的比较[J].中国医学物理学杂志,2011,28(3):2603-2605. 被引量:1
-
6曾自力,滕炳祥,刘兵.肺癌三维适形放疗中脊髓剂量计算的研究[J].中国医学物理学杂志,2011,28(6):2978-2980.
-
7王玉祥,田丹丹,邱嵘,祝淑钗,乔学英.不同时期治疗的Ⅲ期非小细胞肺癌三维适形放疗的靶区剂量分布及疗效比较[J].肿瘤防治研究,2014,41(5):413-417. 被引量:5
-
8周诚忠,夏炎春,夏海波.老年非小细胞肺癌50例三维适形放疗的临床分析[J].肿瘤研究与临床,2007,19(z1). 被引量:2
-
9朱玉珍,冯勤富.放射疗法和化学疗法结合致肺组织损伤的研究进展[J].中国肿瘤,2005,14(8):534-537. 被引量:3
-
10杨凯,江泓,谈旭东,陈林.放射性肺炎80例的影像学表现[J].苏州大学学报(医学版),2006,26(1):130-131. 被引量:5
同被引文献60
-
1李付海,石安辉,朱广迎.局部晚期非小细胞肺癌同步放化疗进展[J].中国肿瘤,2009,18(10):831-834. 被引量:11
-
2周绍兵,刘阳晨,高飞,叶宏勋,赵莺,尹小祥.后程适形放射治疗Ⅲ期非小细胞肺癌[J].现代肿瘤医学,2004,12(5):439-440. 被引量:3
-
3王颖杰,王绿化,王鑫,冯勤付,张红星,肖泽芬,殷蔚伯.91例非小细胞肺癌三维适形放疗的临床分析[J].中华放射肿瘤学杂志,2005,14(4):241-244. 被引量:48
-
4于金明,孙新东.局部晚期非小细胞肺癌累及野照射的研究进展[J].中华放射肿瘤学杂志,2005,14(4):338-341. 被引量:7
-
5余辉,吴一龙,戎铁华,李锦添,王思愚,区伟,林素暇,侯景辉.非小细胞肺癌组织中p53蛋白的表达对预后及术后化放疗疗效的影响[J].肿瘤研究与临床,2006,18(1):16-18. 被引量:12
-
6刘鹏辉,廖国清,王红梅.非小细胞肺癌化疗前后肿瘤标记物水平变化及意义[J].新乡医学院学报,2007,24(1):38-40. 被引量:6
-
7陆舜.晚期非小细胞肺癌化疗的共识[J].中华结核和呼吸杂志,2007,30(2):90-94. 被引量:32
-
8殷蔚伯 谷铣之 刘泰福 等.肿瘤放射治疗学[M].北京:中国协和医科大学联合出版社,1994.502-507.
-
9Nagata Y,Negoro Y,Aoki T,et al.Clinical outcomes of 3D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame[J].Int J Radiat Oncol Biol Phys,2002,52(4):1041.
-
10Sim S,Rosenzweig K E,Schindelheim R,et al.Induction chemotherapy plus three-dimensional conformal radiation therapy in the definitive treatment of locally advanced non-small-cell lung cancer[J].Int J Radiat Oncol Biol Phys,2001,51(3):660.
引证文献8
-
1刘阳晨,高飞,周绍兵,叶宏勋,赵莺,尹小祥.后程三维适形放疗联合紫杉醇化疗治疗局部晚期非小细胞肺癌临床观察[J].实用临床医药杂志,2009,13(7):42-43. 被引量:8
-
2周绍兵,刘阳晨,高飞,叶宏勋,赵莺,尹小祥.后程适形放射治疗联合NP方案同步化疗治疗Ⅲ期非小细胞肺癌[J].临床肿瘤学杂志,2010,15(2):171-172. 被引量:3
-
3张阵,崔淑艳.同步放化疗治疗Ⅲ期非小细胞肺癌60例疗效观察[J].中国实用医药,2011,6(26):49-50. 被引量:5
-
4张艳明,张东峰,赵学红,解晓霞.三维适形放疗同步化疗治疗Ⅲ期非小细胞肺癌临床观察[J].中国辐射卫生,2012,21(3):363-364. 被引量:1
-
5汪宏斌,杨俊泉.局部晚期非小细胞肺癌p53蛋白表达与同步放化疗疗效的关系研究[J].中国全科医学,2014,17(3):282-285. 被引量:14
-
6王娟,顾小林,纪钧.金米益肺汤联合同步放化疗治疗局部晚期非小细胞肺癌的临床观察[J].四川中医,2014,32(9):68-70. 被引量:6
-
7王晓红,姚淑晖,闫淑静,张静,李义慧,杨俊泉.p53蛋白在非小细胞肺癌中表达与放化疗敏感性研究[J].中国煤炭工业医学杂志,2016,18(11):1531-1534. 被引量:4
-
8郑和平,黄梅,蒲廷,郑劲松,郑惠之.加减沙参麦冬汤辅助治疗肺癌患者对免疫功能及不良反应的影响[J].西部医学,2020,32(6):896-899. 被引量:10
二级引证文献51
-
1刘云霞,王国强.小柴胡汤联合化疗对肺癌晚期患者生命质量、免疫能力及炎性反应的影响[J].反射疗法与康复医学,2023,4(13):26-29.
-
2周波,张卫宁,白山,王永强.肺癌患者凝血功能指标变化及其临床价值[J].血栓与止血学,2019,25(1):79-81. 被引量:12
-
3杨玖,洪梅,刘志远,朱诺.益气除痰方联合化疗对中晚期非小细胞肺癌患者近期疗效及患者血清IL-2、TNF-α和免疫功能的影响[J].中华临床医师杂志(电子版),2021,15(12):948-953.
-
4陈科,朴勇瑞,谢国明,张琦,沈燕萍,彭敏,万鹏.同步放化疗加巩固化疗与序贯放化疗治疗老年Ⅲ期非小细胞肺癌的疗效对比[J].中国老年学杂志,2014,34(9):2420-2421. 被引量:29
-
5寇小格,齐博,李小瑞,路平.尿嘧啶替加氟加顺铂联合同步放射治疗干预局部晚期非小细胞肺癌[J].新乡医学院学报,2010,27(2):187-189. 被引量:5
-
6唐爽,李素芳,林灿洁,陈杨生.大分割三维适形放疗治疗老年非小细胞肺癌的疗效分析[J].实用临床医药杂志,2010,14(6):69-70. 被引量:8
-
7周绍兵,刘阳晨,高飞.吉非替尼联合适形放射治疗局部晚期非小细胞肺癌的临床观察[J].中国肿瘤临床与康复,2011,18(3):256-257. 被引量:5
-
8苗磊.同步放化疗治疗Ⅲ期非小细胞肺癌的临床疗效观察[J].求医问药(下半月刊),2012,10(6):60-60. 被引量:1
-
9邓滨.三维适形放疗联合紫杉醇化疗对局部晚期非小细胞肺癌的疗效及不良反应[J].中外医学研究,2012,10(31):26-27. 被引量:7
-
10李新,韩峰,张小涛,张真,韩淑红.NP方案联合同步调强放疗治疗局部晚期非小细胞肺癌的临床观察[J].中国肿瘤临床,2012,29(23):1964-1967. 被引量:13
-
1张业繁.钼靶——捕捉乳腺癌的能手[J].抗癌之窗,2012(12):15-16.
-
2曹卫,高再荣.全身骨显像:发现肿瘤骨转移的能手[J].大众医学,2014,0(12):13-14.
-
3周晖楠,刘广森,曾灿光,陈英福.小细胞肺癌诊断及治疗的商榷 (第二部分 治疗)[J].癌症,1990,9(5):397-400. 被引量:3
-
4陈东福,杨宗贻,谷铣之,张志贤,苗延浚,汪楣,张宏兴,殷蔚伯.180例可手术食管癌单纯放疗的疗效分析[J].中华肿瘤杂志,1996,18(3):195-198. 被引量:12
-
5薄志敏.钼靶——搏捉乳癌的能手[J].中老年保健,2005(1):16-16. 被引量:1
-
6张业繁.钼靶——捕捉乳癌的能手[J].大众健康,2014(2):46-47.
-
7李沛,刘刚,李宏宇,王彦荣.吉西他滨联合顺铂方案治疗中晚期食管癌的临床观察[J].中华肿瘤防治杂志,2009,16(23):1887-1888. 被引量:2
-
8王中凡,张家文.腹壁下动脉插管化疗治疗晚期宫颈癌的临床观察[J].四川肿瘤防治,2000,13(4):235-237. 被引量:1
-
9应学明,陈俊,汤声波.顺铂同步化疗联合尼妥珠单抗用于局部晚期头颈部鳞癌的近期疗效观察[J].中国药房,2012,23(48):4566-4569. 被引量:7
-
10徐刚.非小细胞肺癌治疗进展[J].基层医学论坛,2006,10(9).